NewLake Capital Partners reported $12M in Q3 revenue, $10.3M in adjusted FFO and $17.9M in cash, ending September with no ...

Green Thumb Q3 2026 revenue rose 11.3% to $324.4 million, with $316 million in cash, $58.3 million in operating cash flow and ...

Trulieve Q3 2026 revenue reached $230M with a 64% gross margin, $89M adjusted EBITDA and $327M cash following its NYSE ...

Europe’s entire legal cannabis market is smaller than Missouri’s, by one count. Seth Yakatan of Katan Associates says that’s ...

Cronos Q3 2026 revenue rose 75% to $63.5 million, with adjusted EBITDA up 201%, rapid growth in Germany and Israel, and a ...

The April 23 order moving state-regulated medical cannabis to Schedule III raises the prospect of interstate commerce, but attorneys disagree on whether FDA approval is required first. A June 29 ...

Pennsylvania cannabis legalization gains momentum after Democrats secure a governing trifecta in the 2026 midterms, opening a ...

Massachusetts voters keep adult-use sales, Idaho protects ballot access, Houston deprioritizes possession arrests and ...

Curaleaf Q3 2026 results show record revenue of $352.7 million, up 11%, alongside $77.6 million in adjusted EBITDA and a ...

Cannabis executives and advocates react to the 2026 midterm election results, weighing banking reform, investment prospects, ...

Texas elects cannabis-friendly leaders as its 31.7 million-person market, $5.5 billion hemp industry, and expanding medical ...

The Trump administration is preparing to reclassify marijuana from Schedule I to Schedule III as early as Wednesday, Axios reports, and cannabis stocks jumped, with Curaleaf up 27.54% at the time of ...